McBarron Paul 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 26, 2023
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Purchase
Warrants (right to buy)
2023-12-21+1,886→ 1,886 totalExercise: $3.19From: 2023-12-21Exp: 2030-12-21→ Common Stock (1,886 underlying) - Purchase
Common Stock
2023-12-21$3.31/sh+1,886$6,252→ 33,378 total
Footnotes (2)
- [F1]The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer.
- [F2]Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant.